Search research articles
Contact Us
Filters
Showing results (491-500 of 509) with videos related to
Page
of 51
Sort By:
Nature Communications
|
May 4, 2021
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
Elizabeth M Swisher, Tanya T Kwan, Amit M Oza, et al.
Bulletin Du Cancer
|
March 10, 2019
[Management of epithelial ovarian cancer. Short text drafted from the French joint recommendations of FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa]
Vincent Lavoue, Cyrille Huchon, Cherif Akladios, et al.
Gynecologic Oncology
|
January 22, 2022
Clear cell carcinoma of the endometrium
Giorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 31, 2025
Uterine leiomyosarcoma
Giorgio Bogani, Giuseppe Caruso, Isabelle Ray-Coquard, et al.
Orphanet Journal of Rare Diseases
|
March 11, 2025
Pregnancy-related issues in rare and low-prevalence diseases: results of ERN transversal working group on pregnancy and family planning survey
Dina Zucchi, Diana Marinello, Chiara Tani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2024
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial
Antonio González-Martín, María Jesús Rubio, Florian Heitz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 17, 2020
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
Souad Assaad, Virginie Avrillon, Marie-Line Fournier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2014
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative
Jan Bogaerts, Matthew R Sydes, Nicola Keat, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 30, 2022
Endometrial carcinosarcoma
Giorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
Cancers
|
June 10, 2022
No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?
Yohan Fayet, Christine Chevreau, Gauthier Decanter, et al.
Page
of 51
Search research articles
Search
Showing results (491-500 of 509) with videos related to
Sort By:
Page
of 51
Nature Communications
|
May 4, 2021
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
Elizabeth M Swisher, Tanya T Kwan, Amit M Oza, et al.
Bulletin Du Cancer
|
March 10, 2019
[Management of epithelial ovarian cancer. Short text drafted from the French joint recommendations of FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa]
Vincent Lavoue, Cyrille Huchon, Cherif Akladios, et al.
Gynecologic Oncology
|
January 22, 2022
Clear cell carcinoma of the endometrium
Giorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 31, 2025
Uterine leiomyosarcoma
Giorgio Bogani, Giuseppe Caruso, Isabelle Ray-Coquard, et al.
Orphanet Journal of Rare Diseases
|
March 11, 2025
Pregnancy-related issues in rare and low-prevalence diseases: results of ERN transversal working group on pregnancy and family planning survey
Dina Zucchi, Diana Marinello, Chiara Tani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2024
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial
Antonio González-Martín, María Jesús Rubio, Florian Heitz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 17, 2020
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
Souad Assaad, Virginie Avrillon, Marie-Line Fournier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2014
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative
Jan Bogaerts, Matthew R Sydes, Nicola Keat, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 30, 2022
Endometrial carcinosarcoma
Giorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
Cancers
|
June 10, 2022
No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?
Yohan Fayet, Christine Chevreau, Gauthier Decanter, et al.
Page
of 51